Primary pulmonary hypertension is an increase in blood pressure in the pulmonary artery, caused by a rare lung disorder. The effects of primary pulmonary hypertension, while often mostly genetic, can be aggravated by poor diet or lack of adequate exercise. (The pulmonary artery is the blood vessel that distributes blood from the right side of the heart to the lungs. This distribution of blood is known as pulmonary circulation.)
Primary pulmonary hypertension results from the hardening or stiffening of the blood vessels that supply blood to the lungs. As a result of this, the right ventricle has to work harder to pump blood forward. This stress on the heart enlarges and thickens the right ventricle and increases blood pressure. Primary pulmonary hypertension occurs without any underlying heart or lung disease.
Symptoms of primary pulmonary hypertension include chest pain, especially during physical exertion, progressive weakness, shortness of breath, dizziness, fainting, fatigue, coughing up blood, swollen ankles and legs. More severe symptoms include inability to perform minimal activities; can result in the disease progressing to an advanced stage.
The causes of primary pulmonary hypertension have not yet been identified and are rarely discovered during a routine medical checkup. Tests for the diagnosis of primary pulmonary Indian Suhagra include an electrocardiogram (ECG), chest x-ray, ultrasound of the heart, lung nuclear scan, chest scan, cardiac catheterization of the right heart, and pulmonary arteriography. Once diagnosed, doctors recommend a specific course of treatment, based on the patient’s age, general health, extent of the disease, and tolerance to various medications and therapies.
The problem with treatment is that there is no way to predict how an individual’s body will respond to drugs before they have been administered. What works for some people may not work for everyone. Because this is true, a doctor will commonly prescribe a series of treatments for a person in an effort to determine what will work best.
Primary pulmonary hypertension is a progressive disorder that is often fatal. Because of this, the best option for a person might be a lung transplant. It is a treatment option that is available to people under the age of 65 who not only have PPH, but their PPH is not responding to prescription drug treatment. When a transplant is done, 73% of patients survive one year after their transplant. 55% survive 3 years and 45% survive up to 5 years after transplantation.
A secondary benefit of transplantation is that there is an immediate reduction in pressure in the pulmonary artery. This pressure reduction allows for more function on the right side of the heart. Primary pulmonary hypertension has not been reported in people after lung transplantation.